Nucleic Acid Amplification Circuit-Based Hydrogel (NACH) Assay for One-Step Detection of Metastatic Gastric Cancer-Derived Exosomal miRNA
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a novel nucleic acid amplification circuit-based hydrogel (NACH) assay for detecting exosomal microRNAs in metastatic gastric cancer (GC). The assay offers rapid, sensitive, on-site detection for improved GC diagnostics.
Area Of Science
- Biochemistry
- Molecular Biology
- Oncology
Background
- Gastric cancer (GC) is a prevalent malignancy with diverse prognoses.
- Epithelial-mesenchymal transition (EMT) promotes GC invasion and metastasis.
- Exosomal microRNAs (miRNAs) are key biomarkers in cancer progression.
Purpose Of The Study
- To develop a nucleic acid amplification circuit-based hydrogel (NACH) assay for identifying exosomal miRNAs in metastatic GC.
- To enable rapid, sensitive, and on-site detection of specific cancer-related miRNAs.
Main Methods
- Utilized rolling circle amplification within a hydrogel matrix.
- Targeted specific miRNAs: miRNA-21 (oncogene) and miRNA-99a (EMT promoter).
- Immobilized specific amplification probes for a one-step reaction.
Main Results
- Achieved a detection limit of 1 fM for both miRNA-21 and miRNA-99a.
- Demonstrated comparable fluorescence intensity to qRT-PCR using various sample types.
- Validated diagnostic performance with clinical GC patient samples using a portable fluorometer.
Conclusions
- The NACH assay provides a robust platform for sensitive, on-site detection of exosomal miRNAs.
- This technology holds significant potential for the genetic diagnosis and point-of-care testing of gastric cancer.

